IN GYNECOLOGIC CANCERS Madrid, 11 May, 2018
Transcript of IN GYNECOLOGIC CANCERS Madrid, 11 May, 2018
Meeting Directors:Dr. Francisco Javier de Santiago · MD Anderson Cancer Center Madrid, Spain
Dr. Robert L. Coleman · The University of Texas MD Anderson Cancer Center, Houston, USADr. Raúl Márquez · MD Anderson Cancer Center Madrid, Spain
Registrations: www.mdanderson.es/embracingnewstandards
6th
MD ANDERSON INTERNATIONAL MEETING IN
I N G Y N E C O L O G I C C A N C E R SEMBRACING NEW STANDARDS OF CARE
@MDAnderson_ES
PRELIMINARY PROGRAM
Madrid, 9th -11th May, 2018
6th
MD ANDERSON INTERNATIONAL MEETING IN
I N G Y N E C O L O G I C C A N C E R SEMBRACING NEW STANDARDS OF CARE
ANDERSON
I N G Y N E CEMBRACING N
MMD AAANNN
11:00 - 11:15 WELCOME AND INTRODUCTION Dr. Pedro Luis Cobiella Hospiten Group President Dr. Francisco Javier de Santiago MD Anderson Cancer Center Madrid, Spain Dr. Robert L. Coleman The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Raúl Márquez MD Anderson Cancer Center Madrid, Spain Dr. Shannon N. Westin The University of Texas MD Anderson Cancer Center, Houston, USA
SURGERY IN OVARIAN CANCERModerators:
Dr. Robert L. ColemanThe University of Texas MD Anderson Cancer Center, Houston, USA
Dr. Francisco Javier de SantiagoMD Anderson Cancer Center Madrid, Spain
11:15 - 11:35 Surgical trials in gynecologic oncology. A critical appraisal Dr. David Cibula General University Hospital and Charles University in Prague, The Czech Republic
11:35 - 11:55 Laparoscopy in interval debulking surgery in ovarian cancer Dr. Giovanni Aletti Istituto Europeo di Oncologia, Milan, Italy
11:55 - 12:15 Ovarian cancer. Moon shot program Dr. Anil Sood The University of Texas MD Anderson Cancer Center, Houston, USA
12:15 - 12:35 Early recovery after surgery program (ERAS) Dr. Larissa A. Meyer The University of Texas MD Anderson Cancer Center, Houston, USA
12:35 - 13:00 Questions & Discussion
LIST OF FACULTY
Wednesday, May 9th, 2018
Dr. Giovanni AlettiIstituto Europeo di Oncologia, Milan, Italy
Dr. Sonsoles AlonsoMD Anderson Cancer Center Madrid, Spain
Dr. Alessandro BudaSan Gerardo Hospital, Monza, Italy
Dr. Natalia CarballoMD Anderson Cancer Center Madrid, Spain
Dr. Antonio CasadoHospital Clínico Univ. San Carlos, Madrid, Spain
Dr. David CibulaGeneral University Hospital and Charles University in Prague, The Czech Republic
Dr. Robert L. ColemanThe University of Texas MD Anderson Cancer Center, Houston, USA
Dr. Francisco Javier de SantiagoMD Anderson Cancer Center Madrid, Spain
Dr. Santiago DomingoHospital Univ. i Politècnic La Fe, Valencia, Spain
Dr. María Fernández-ChereguiniMD Anderson Cancer Center Madrid, Spain
Dr. Gwenaël FerronInstitut Claudius Regaud - IUCT Oncopole, Toulouse, France
Dr. Francisco Javier García PradoMD Anderson Cancer Center Madrid, Spain
Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France
Dr. Michael J. HalaskaCharles University in Prague, The Czech Republic
Dr. Amir Anthony JazaeriThe University of Texas MD Anderson Cancer Center, Houston, USA
Dr. K. Rainer KimmigEssen University Hospital, Essen, Germany
Dr. Raúl MárquezMD Anderson Cancer Center Madrid, Spain
Dr. Sergio MartínezHospital Univ. Germans Trias i Pujol, Barcelona, Spain
Dr. Larissa A. MeyerThe University of Texas MD Anderson Cancer Center, Houston, USA
Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center, Phoenix, USA
Dr. Jordi PonceHospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
Dr. Andrés PovedaFundación Instituto Valenciano de Oncología, Valencia, Spain
Dr. Patricia PraderaMD Anderson Cancer Center Madrid, Spain
Dr. Eric Pujade-LauraineHôpital Hôtel-Dieu, Paris, France
Dr. Jose Alejandro Rauh-HainThe University of Texas MD Anderson Cancer Center, Houston, USA
Dr. Brian M. SlomovitzUniversity of Miami Hospital, Miami, USA
Dr. Anil SoodThe University of Texas MD Anderson Cancer Center, Houston, USA
Dr. Gemma ToledoMD Anderson Cancer Center Madrid, Spain
Dr. Shannon N. WestinThe University of Texas MD Anderson Cancer Center, Houston, USA
CONTROVERSIES IN FRONTLINE OVARIAN CANCERModerators:
Dr. Santiago DomingoHospital Univ. i Politècnic La Fe, Valencia, Spain
Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France
17:40 - 18:00 Guided lymphadenectomy in ovarian cancer. Any sense in LION´s era? Dr. K. Rainer Kimmig Essen University Hospital, Essen, Germany
18:00 - 18:30 Debate: IP chemotherapy in ovarian cancer18:00 - 18:15 Pro Dr. Raúl Márquez MD Anderson Cancer Center Madrid, Spain
18:15 - 18:30 Against Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph’s Hospital and Medical
Center, Phoenix, USA
18:30 - 18:45 Questions & Discussion
KEYNOTE LECTUREModerator:
Dr. Francisco Javier de SantiagoMD Anderson Cancer Center Madrid, Spain
13:00 - 13:40 Target microenvironmental opportunities in ovarian cancer Dr. Robert L. Coleman The University of Texas MD Anderson Cancer Center, Houston, USA
13:40 - 15:10 Lunch
FIRST LINE TREATMENT OF OVARIAN CANCER.TARGET DISCOVERY AND NOVEL THERAPEUTICS
Moderators:Dr. Raúl Márquez
MD Anderson Cancer Center Madrid, SpainDr. Giovanni Aletti
Istituto Europeo di Oncologia, Milan, Italy
15:10 - 15:30 Predicting resectability for primary debulking surgery in MD Anderson Cancer Center Madrid
Dr. Francisco Javier de Santiago MD Anderson Cancer Center Madrid, Spain
15:30 - 15:50 Principles and concepts of cytoreductive surgery. Importance of surgical training
Dr. Sergio Martínez Hospital Univ. Germans Trias i Pujol, Barcelona, Spain
15:50 - 16:10 Optimal setting for antiangiogenic agents in first line. Evidence or preference
Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph’s Hospital and Medical
Center, Phoenix, USA
16:10 - 16:30 Neoadjuvant setting Dr. Raúl Márquez MD Anderson Cancer Center Madrid, Spain
16:30 - 16:50 HIPEC. Do we have any evidence so far? Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France
16:50 - 17:10 Questions & Discussion
17:10 - 17:40 Coffee break
11:30 - 12:00 Stage Ib2 cervical cancer. Other options than chemoradiation
11:30 - 11:45 Radiotherapist Dr. Natalia Carballo MD Anderson Cancer Center Madrid, Spain
11:45 - 12:00 Gynecologic oncologist Dr. Michael J. Halaska Charles University in Prague, The Czech Republic
12:00 - 12:30 Questions & Discussion
KEYNOTE LECTUREModerator:
Dr. Raúl MárquezMD Anderson Cancer Center Madrid, Spain
12:30 - 13:15 Inmunotherapy updates: can we use inmune system to treat gynecological cancer?
Dr. Amir Anthony Jazaeri The University of Texas MD Anderson Cancer Center, Houston, USA
13:15 - 14:45 Lunch
ENDOMETRIAL CANCERModerators:
Dr. Sergio MartínezHospital Univ. Germans Trias i Pujol, Barcelona, Spain
Dr. Robert L. ColemanThe University of Texas MD Anderson Cancer Center, Houston, USA
14:45 - 15:05 Update on conservative treatment. Ongoing trials Dr. Shannon N. Westin The University of Texas MD Anderson Cancer Center, Houston, USA
15:05 - 15:45 The genomic data to clinical application in endometrial cancer patients. Clinical cases
Dr. Sonsoles Alonso MD Anderson Cancer Center Madrid, Spain
CHALLENGING CASES IN GYNECOLOGICAL CANCERModerators:
Dr. Eric Pujade-LauraineHôpital Hôtel-Dieu, Paris, France
Dr. Jordi PonceHospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
08:30 - 08:50 Management of advanced stage and recurrent low grade serous ovarian cancer
Dr. Brian M. Slomovitz University of Miami Hospital, Miami, USA
08:50 - 09:10 Finding the patient for pelvic exenteration Dr. Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France
09:10 - 09:30 Contemporary management of uterine leiomyosarcoma Dr. Jose Alejandro Rauh-Hain The University of Texas MD Anderson Cancer Center, Houston, USA
09:30 - 10:00 Questions & Discussion
10:00 - 10:30 Coffee break
CERVICAL CANCERModerators:
Dr. Gwenaël FerronInstitut Claudius Regaud - IUCT Oncopole, Toulouse, France
Dr. Francisco Javier de SantiagoMD Anderson Cancer Center Madrid, Spain
10:30 - 11:00 Contemporary management of advanced and recurrent cervical cancer
Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph’s Hospital and Medical
Center, Phoenix, USA
11:00 - 11:30 Rationale for only sentinel node in cervical cancer. Must we subselect patients? Dr. David Cibula General University Hospital and Charles University in Prague, The Czech Republic
Thursday, May 10th, 2018
MISCELLANEOUSModerators:
Dr. Sonsoles AlonsoMD Anderson Cancer Center Madrid, Spain
Dr. María Fernández-ChereguiniMD Anderson Cancer Center Madrid, Spain
08:30 - 08:50 Universal genetic testing Dr. Shannon N. Westin The University of Texas MD Anderson Cancer Center, Houston, USA
08:50 - 09:10 Social and psycological support Dr. Patricia Pradera MD Anderson Cancer Center Madrid, Spain
09:10 - 09:30 Quality of life and patient reported outcomes. How do they inform clinical trials? Dr. Larissa A. Meyer The University of Texas MD Anderson Cancer Center, Houston, USA
09:30 - 09:45 Questions & Discussion
09:45 - 10:45TUMOR BOARD
Moderators:Dr. Francisco Javier de Santiago
MD Anderson Cancer Center Madrid, SpainDr. Robert L. Coleman
The University of Texas MD Anderson Cancer Center, Houston, USADr. Raúl Márquez
MD Anderson Cancer Center Madrid, Spain
Panel:Dr. David Cibula
Dr. Gemma ToledoDr. Eric Pujade-LauraineDr. Shannon N. Westin
Dr. Natalia CarballoDr. Francisco Javier García Prado
10:45 - 11:15 Coffee break
15:45 - 16:25 Stage IIIC2 endometrial cancer15:45 - 16:05 Radiotherapy Dr. Natalia Carballo MD Anderson Cancer Center Madrid, Spain
16:05 - 16:25 Chemotherapy Dr. Brian M. Slomovitz University of Miami Hospital, Miami, USA
16:25 - 16:45 Sentinel node mapping algorithm versus selective lymphadenectomy in early stage endometrial cancer
Dr. Alessandro Buda San Gerardo Hospital, Monza, Italy
16:45 - 17:05 ICG guided peritoneal mesometrial resection with targeted compartmental lymphadenectomy in endometrial cancer
Dr. K. Rainer Kimmig Essen University Hospital, Essen, Germany
17:05 - 17:35 Questions & Discussion
17:35 - 18:05 Coffee break
PERSONALIZING DECISIONS IN RECURRENT GYNECOLOGIC CANCER TREATMENT
Moderators:Dr. Brian M. Slomovitz
University of Miami Hospital, Miami, USA Dr. Amir Anthony Jazaeri
The University of Texas MD Anderson Cancer Center, Houston, USA
18:05 - 18:25 Prolonging PFS with non-platinum in ovarian cancer Dr. Antonio Casado Hospital Clínico Univ. San Carlos, Madrid, Spain
18:25 - 18:45 PARPi’s: Where are we and where are we going? Dr. Andrés Poveda Fundación Instituto Valenciano de Oncología, Valencia, Spain
18:45 - 19:05 Treatments in novel targets in the recurrent setting Dr. Eric Pujade-Lauraine Hôpital Hôtel-Dieu, Paris, France
19:05 - 19:30 Questions & Discussion
Friday, May 11th, 2018
11:15 - 14:00VIDEO WORKSHOP
11:15 - 12:45 EXPERTS
11:15 - 11:45 Open surgery Dr. Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France
11:45 - 12:15 Laparoscopic surgery Dr. Francisco Javier de Santiago MD Anderson Cancer Center Madrid, Spain
12:15 - 12:45 Robotic surgery Dr. Jose Alejandro Rauh-Hain The University of Texas MD Anderson Cancer Center, Houston, USA
12:45 - 14:00 YOUNG SURGEONS
First MD Anderson Cancer Center Madrid video contestin gyne-onco surgery for young surgeons
RULES & GUIDELINES AVAILABLE ON THE WEBSITE
14:00 CLOSING REMARKS Dr. Francisco Javier de Santiago MD Anderson Cancer Center Madrid, Spain Dr. Robert L. Coleman The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Raúl Márquez MD Anderson Cancer Center Madrid, Spain Dr. Shannon N. Westin The University of Texas MD Anderson Cancer Center, Houston, USA
VENUE:Auditorio Duques de PastranaPaseo de la Habana, 208 · 28016 Madrid (Spain)
ORGANIZED BY:
LANGUAGE:Simultaneous translation English/Spanish will be provided
ACCREDITATION:Applications for CME credits have been forwarded to the Spanish Accreditation Council for Continuing Medical Education and to the Accreditation Council for Oncology in Europe (ACOE). ACOE accreditation is endorsed by EACCME®, the European Accreditation Council for Continuous Medical Education, an institution of the European Union of Medical Specialists (UEMS). �e UEMS-EACCME® and the AMA (American Medical Association) recognize each other’s CME credits.
With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid.
UNDER THE AUSPICES OF:
SPONSORSHIP:
Gold
Silver
Bronze
Collaborator
MEETING SECRETARIAT:
C/ Monasterios de Suso y Yuso 34, 4-14-2 · 28049 Madrid Phone: (+34) 91 372 02 03 e-mail: [email protected]: www.mdanderson.es/embracingnewstandards